Pancreatitis risk rises with popular weight loss drugs: study
Patients using GLP-1 receptor agonists for weight loss are nine times more likely to develop pancreatitis than those taking bupropion–naltrexone, Canadian researchers say. Use of…
Patients using GLP-1 receptor agonists for weight loss are nine times more likely to develop pancreatitis than those taking bupropion–naltrexone, Canadian researchers say. Use of…
Plastic surgeons are seeking new Medicare items for gender-affirming interventions for transgender adults, including masculinising chest surgery for those assigned female at birth. The Australian…
The TGA is investigating reports of intestinal obstruction in patients using semaglutide and may consider updating the product information to include a warning about ileus. …
Months-long shortages of oestrogen patches have left doctors “annoyed” and have added to their workload when prescribing menopausal hormone therapy, a leading GP says. A…
Prompt initiation of testosterone therapy significantly reduces depression and suicidality in transgender adults, shows a first-of-its-kind Australian study. Melbourne doctors compared mental health outcomes in…
Metformin has clear benefits for women with PCOS and should be considered for those with overweight or obesity to improve weight loss, insulin resistance and…
Elevated serum anti-müllerian hormone can now be used as an alternative to pelvic ultrasound to aid diagnosis of PCOS, according to updated guidelines released this…
Need to know: Congenital adrenal hyperplasia (CAH) consists of a group of autosomal recessive disorders resulting in enzymatic defects in cortisol biosynthesis. Approximately 95% of…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.